REVERSIBLE AIRWAYS OBSTRUCTION

This adverse event was reported 371 times

REVERSIBLE AIRWAYS OBSTRUCTION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MEPOLIZUMAB 153 0.0066
1 SILODOSIN 26 0.0061
2 CICLESONIDE 52 0.0055
3 TERBUTALINE SULFATE 6 0.0045
4 GABAPENTIN ENACARBIL 10 0.0044
5 THEOPHYLLINE 32 0.0034
6 BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE 165 0.0022
7 IPRATROPIUM BROMIDE 56 0.0021
8 TIOTROPIUM BROMIDE INHALATION SPRAY 13 0.0020
9 AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE 6 0.0020
See all drugs enriched for association with REVERSIBLE AIRWAYS OBSTRUCTION

REVERSIBLE AIRWAYS OBSTRUCTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 153 0.0065
1 Anti-IgE [EPC] 78 0.0016
2 Leukotriene Receptor Antagonist [EPC] 13 0.0008
3 Nitroimidazole Antimicrobial [EPC] 28 0.0005
4 Cholinergic Nicotinic Agonist [EPC] 28 0.0005
5 Aldosterone Antagonist [EPC] 55 0.0005
6 Methylxanthine [EPC] 71 0.0004
7 Serotonin Reuptake Inhibitor [EPC] 24 0.0004
8 Nitrate Vasodilator [EPC] 25 0.0003
9 Corticosteroid [EPC] 232 0.0003
See all drug classes enriched for association with REVERSIBLE AIRWAYS OBSTRUCTION